
N&N Scientific Inc Profile last edited on: 12/24/14
CAGE: 4LTW9
UEI:
Business Identifier: antiviral drug against the Herpes and Orthopox virus families Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 06
County: Montgomery
Congr. District: 06
County: Montgomery
Public Profile
N&N Scientific, Inc. (N&N) is a pharmaceutical company whose first new product candidate is N-MethanoCarbaThymidine (N-MCT), a promising antiviral drug that has shown potent and selective activity against the Herpes and Orthopox virus families. N&N proposes to develop N-MCT as a therapeutic against the Herpesviridae, Papillomaviridae and Poxviridae genera of Class I dsDNA viruses, including HSV-1, HSV-2, HSV-8, VZV, EBV, smallpox, Vaccinia, cowpox, and HPV.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2014 | 2 | NIH | $3,479,710 | |
Project Title: N-Methanocarbathymidine (N-Mct) for the Treatment of Herpes and Pox Virus Infecti |
Key People / Management
Aquilur Rahman
Company News
There are no news available.